Officials from the drugmakers will testify at the hearing, according to a notice sent on Monday from the House Energy and Commerce Committee. Pfizer makes Lipitor, and Johnson & Johnson sells Procrit. Vytorin is sold through a joint venture of Merck & Co Inc and Schering-Plough Corp.
WASHINGTON (Reuters) - U.S. lawmakers will examine advertising campaigns for the cholesterol drugs Lipitor and Vytorin plus anemia drug Procrit at a hearing on Thursday, a U.S. House of Representatives committee said.
Officials from the drugmakers will testify at the hearing, according to a notice sent on Monday from the House Energy and Commerce Committee. Pfizer makes Lipitor, and Johnson & Johnson sells Procrit. Vytorin is sold through a joint venture of Merck & Co Inc and Schering-Plough Corp.
(Reporting by Lisa Richwine)
